Ian J Kulac

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Aortic Stenosis

Ejection Fraction

Top Venues

Journal of the American Heart Association

Circulation. Heart failure

This page only lists publications with an associated author ORCID identifier.

Publications

Niteesh K Choudhry, Muthiah Vaduganathan, Brian Lee Claggett, Ian J Kulac, Inder S Anand, Akshay S Desai, James C Fang, Adrian F Hernandez, Pardeep S Jhund, Mikhail Naum Kosiborod, Marc S Sabatine, Sanjiv J Shah, Orly Vardeny, John Joseph Valentine McMurray, Scott D Solomon, Thomas Andrew Gaziano
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials. Journal of the American Heart Association (2024)
Niteesh K Choudhry, Muthiah Vaduganathan, Brian Lee Claggett, Ian J Kulac, Inder S Anand, Akshay S Desai, James C Fang, Adrian F Hernandez, Pardeep S Jhund, Mikhail Naum Kosiborod, Marc S Sabatine, Sanjiv J Shah, Orly Vardeny, John Joseph Valentine McMurray, Scott D Solomon, Thomas Andrew Gaziano
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials. Journal of the American Heart Association 13 (5) (2024)
Niteesh K Choudhry, Muthiah Vaduganathan, Brian Lee Claggett, Ian J Kulac, Inder S Anand, Akshay S Desai, James C Fang, Adrian F Hernandez, Pardeep S Jhund, Mikhail Naum Kosiborod, Marc S Sabatine, Sanjiv J Shah, Orly Vardeny, John Joseph Valentine McMurray, Scott D Solomon, Thomas Andrew Gaziano
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials. Journal of the American Heart Association 13 (5) (2024)
Niteesh K Choudhry, Muthiah Vaduganathan, Brian Lee Claggett, Ian J Kulac, Inder S Anand, Akshay S Desai, James C Fang, Adrian F Hernandez, Pardeep S Jhund, Mikhail Naum Kosiborod, Marc S Sabatine, Sanjiv J Shah, Orly Vardeny, John Joseph Valentine McMurray, Scott D Solomon, Thomas Andrew Gaziano
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials. Journal of the American Heart Association 13 (5) (2024)
Niteesh K Choudhry, Muthiah Vaduganathan, Brian Lee Claggett, Ian J Kulac, Inder S Anand, Akshay S Desai, James C Fang, Adrian F Hernandez, Pardeep S Jhund, Mikhail Naum Kosiborod, Marc S Sabatine, Sanjiv J Shah, Orly Vardeny, John Joseph Valentine McMurray, Scott D Solomon, Thomas Andrew Gaziano
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials. Journal of the American Heart Association 13 (5) (2024)
Niteesh K Choudhry, Muthiah Vaduganathan, Brian Lee Claggett, Ian J Kulac, Inder S Anand, Akshay S Desai, James C Fang, Adrian F Hernandez, Pardeep S Jhund, Mikhail Naum Kosiborod, Marc S Sabatine, Sanjiv J Shah, Orly Vardeny, John Joseph Valentine McMurray, Scott D Solomon, Thomas Andrew Gaziano
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials. Journal of the American Heart Association 13 (5) (2024)
Alexander Peikert, Felipe A Martinez, Muthiah Vaduganathan, Brian Lee Claggett, Ian J Kulac, Akshay S Desai, Pardeep S Jhund, Rudolf A de Boer, David L DeMets, Adrian F Hernandez, Catherine M Viscoli, Mikhail Naum Kosiborod, Carolyn Su Ping Lam, Sanjiv J Shah, Tsvetana Katova, Béla Merkely, Orly Vardeny, Ulrica Wilderäng, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial. Circulation. Heart failure 15 (10) (2022)
Xiaowen Wang, Muthiah Vaduganathan, Brian Lee Claggett, Sheila M Hegde, Maria Pabon, Ian J Kulac, Orly Vardeny, Eileen O'Meara, Shelley Zieroth, Tzvetana Katova, Martina M McGrath, Anne-Catherine Pouleur, Pardeep S Jhund, Akshay S Desai, Catherine M Viscoli, Mikhail Naum Kosiborod, Rudolf A de Boer, Lars Valeur Køber, Marc S Sabatine, Felipe A Martinez, Piotr Ponikowski, Sanjiv J Shah, Adrian F Hernandez, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon, Carolyn Su Ping Lam
Sex Differences in Characteristics, Outcomes and Treatment Response with Dapagliflozin across the Range of Ejection Fraction in Patients with Heart Failure: Insights from DAPA-HF and DELIVER. Circulation (2022)